antibody-drug conjugate

Marseille, France | July 21, 2026 Innate Pharma SA has announced the completion of enrollment in the dose-escalation portion...

AURORA, Colo., July 17, 2026 Researchers at the University of Colorado Anschutz Medical Campus have reported that the market...

PRAGUE, Basel & BOSTON, July 14, 2026 SOTIO Biotech announced that the U.S. Food and Drug Administration (FDA) has...

BALLERUP, Denmark, July 9, 2026 LEO Pharma A/S has announced positive results from the Phase 2 TRAPEDS-1 clinical trial...

BOTHELL, Wash., July 8, 2026 Immunome, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted...

RANCHO CORDOVA, Calif., June 18, 2026 SK pharmteco, a leading global contract development and manufacturing organization (CDMO), has announced...

SOUTH SAN FRANCISCO, Calif., June 17, 2026 Genentech, a member of the Roche Group, has reached a significant regulatory...

MUMBAI, India & NAPLES, Fla., June 17, 2026 Lupin Limited, a leading global pharmaceutical company, has announced the launch...

SHANGHAI, China & CAMBRIDGE, Massachusetts, USA – June 9, 2026 Zai Lab has received approval from China’s National Medical...

CRANFORD, N.J., June 1, 2026 Citius Oncology has announced encouraging Phase 1 clinical findings evaluating LYMPHIR® (denileukin diftitox-cxdl) in...